Treatment Action Group (TAG) is deeply disappointed by President Obama’s proposed cuts to PEPFAR (President’s Emergency Plan for AIDS Relief) and bilateral TB funds, freezing of NIH (National Institutes of Health) research as well as the insufficient attention to the worsening domestic AIDS crisis in the administration's fiscal year 2013 budget plan.

We need a new vision for TB writes AIDS and TB activist Mark Harrington, Executive Director of the Treatment Action Group.

Two experimental drugs for the treatment of MDR TB have completed phase II clinical trials.

A team from Stellenbosch University's Desmond Tutu TB Centre will be monitoring 200 children at the Brooklyn Chest Hospital in Cape Town over the next five years in a potentially groundbreaking trial.

The Bill & Melinda Gates Foundation today announced $7.7 million in funding for 10 new grants to identify biomarkers for diagnosing tuberculosis (TB) in low-resource settings.

The management of tuberculosis cases in the European Union (EU) is not meeting international standards, according to new research.

Although recent press attention has highlighted the problematic use of TB serological tests by medical providers in India, a new paper in The European Respiratory Journal (Widespread use of serological tests for tuberculosis: data from 22 high-burden countries) demonstrates that the use of these tests is much wider spread.

Tuberculosis is the number one killer of Africans in South Africa, according to the latest South Africa Survey, published by the South African Institute of Race Relations in Johannesburg last week.

The February issue of the World Health Organization bulletin.